The abnormal expression of CENPF has been reported [11] in multiple cancers, including prostate cancer [50], HCC [15] and nasopharyngeal carcinoma [51], indicating that high CENPF expression is a malignant indicator. This evidence concerns the gene CENPF and prostate cancer.